ESC 365 - SGLT2 inhibitors and heart failure: expensive diuretics or added value?

ESC Premium Access

SGLT2 inhibitors and heart failure: expensive diuretics or added value?

Session: SGLT2 inhibitors and cardiovascular outcomes

Topic: Diabetes and the Heart

Speaker: Doctor M. Kosiborod (Kansas City, US)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

55 presentations

9 followers

3 more presentations in this session

SGLT2 inhibitors and atherosclerosis-related outcomes: the good and the bad

Speaker: Professor A. Norhammar (Stockholm, SE)

SGLT2 inhibitors: is the benefit related to renal outcomes?

Speaker: Professor A. Ceriello (Milan, IT)

Panel discussion: how should cardiologists use SGLT2 inhibitors in clinical practice?

Access the full session

SGLT2 inhibitors and cardiovascular outcomes

Speakers: Doctor M. Kosiborod, Professor A. Norhammar, Professor A. Ceriello

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources